Commercialization Reports
ISR utilizes our primary and secondary market research experience to provide novel insight into pharmaceutical industry trends and issues affecting pharmaceutical sales and marketing organizations. The topics ISR covers often requires multiple research methodologies in order to deliver actionable recommendations.
Call us at +1 (919) 301-0106 for more information on our Commercialization Reports, or email us at sales@isrreports.com.
Categories
Showing all 14 results
-
Select options Clinical Library , Commercialization Reports , Department Models & Structures Reports 17 Jul 2018Pharma’s MSL Department Structures
$3,960.00 – $7,920.00 -
Select options Commercialization Reports 24 Jan 2017
Specialty Pharmacy Quality Benchmarking and Market Overview
$4,460.00 – $8,920.00 -
Select options Commercialization Reports 13 Apr 2016
Personalized Medicine’s Effect on Oncologists’ Treatment Regimens
$2,960.00 – $5,920.00 -
Select options Commercialization Reports 29 Mar 2016
Medical Science Liaisons in Oncology
$4,900.00 – $9,800.00 -
Select options Commercialization Reports 01 Feb 2016
Electronic Detailing In Europe: Value And Outcomes
$4,960.00 – $9,920.00 -
Select options Service Provider Quality Benchmarking Reports , Commercialization Reports 29 Oct 2015
Healthcare Advertising Agency Quality Benchmarking (2015)
$4,960.00 – $9,920.00 -
Select options Commercialization Reports 08 Sep 2014
The Sunshine Act: Impact on US Physician Behavior
$4,900.00 – $9,800.00 -
Select options Commercialization Reports 22 Aug 2014
Pharmaceutical Detailing: In-Person vs. Electronic vs. Phone
$4,900.00 – $9,800.00 -
Select options Commercialization Reports 26 Feb 2013
Sunshine Act: Pharma Impact – Changes in US Physician Behavior
$4,900.00 – $9,800.00 -
Select options Commercialization Reports 05 Dec 2012Adoption and Use of eDetailing vs. In-person Detailing in Europe
$4,900.00 – $9,800.00 -
Select options Commercialization Reports 15 Jun 2012
MSL and Sales Strategies for the US Oncology Market
$4,900.00 – $9,800.00 -
Select options Commercialization Reports 17 Jan 2012
US Payers: Comparative Effectiveness Research (CER) and Formulary Decision-making
$4,900.00 – $9,800.00 -
Select options Commercialization Reports 11 Jan 2012
Electronic Detailing vs. In-person Detailing (US)
$4,900.00 – $9,800.00 -
Select options Commercialization Reports 13 Sep 2011
Improving Adherence and Compliance: The Pharmacist’s View
$4,900.00 – $7,350.00
